RGEN: repligen.com Company Sales Revenue

Repligen - graphic logo of issuer RGEN

Geopolitical fragmentation is hindering the export of precision bio-equipment and blocking the supply of consumables. Repligen Corporation (RGEN) sales volumes clearly demonstrate these risks, while the value of 0.81 reflects the metric's balance. The scientific community's high level of trust in RGEN technologies, combined with the gradual overcoming of the destocking phase, creates a foundation for long-term growth in the gene therapy segment.

Company Revenue: Repligen (RGEN) for 07/04/2022 - 11/14/2026

Analytical breakdowns for Repligen Corporation

- current price and projected stock value:
Share Price Repligen Inc.|RGEN - Consensus Target
- market capitalization information:
Market Value Repligen Corporation|RGEN - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value per Share Repligen|RGEN - Company Book Value|Market-to-Book Ratio repligen.com|RGEN - Aggregate Company Assets
- debt and solvency information:
All Debt to Shareholders' Equity Ratio Repligen Corporation|RGEN - Long-Term Debt to Equity|Current Liabilities to Equity Repligen Corp|RGEN - Company Debts|Debts to Book Value Repligen Corporation|RGEN - Company Long-Term Debt|Company Short-Term Loans and Borrowings Repligen|Quick Ratio repligen.com
- company profitability and valuation multiples indicators:
RGEN - Net Income|Future Net Profit Repligen Corporation|RGEN - P/E Multiple|Market Cap to Projected Earnings repligen.com|RGEN - Price/Earnings to Growth Ratio|Company Value to EBITDA Repligen Corporation|RGEN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Repligen|RGEN - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months repligen.com|RGEN - Earnings growth in current year|Net earnings per one share growth forecast for next year Repligen Corporation
- sales volume and revenue indicators:
RGEN - Revenue and Sales Volume|Company Expected Sales Volume Repligen Inc.|RGEN - Price-to-Revenue Ratio|Market Cap to Projected Revenue Repligen Corporation
Comprehensive company analysis:RGEN (Repligen Inc.)
Flagship merchandise of repligen.com

Repligen Corporation (RGEN) provides high-tech delivery of biofiltration systems for the pharmaceutical industry, where logistical precision directly determines commercial success. The daily trading volume reflected in the company's sales statistics on GURU.Markets measures current liquidity and operational activity, allowing investors to assess the business's financial stability and promptly identify risks of a deep portfolio drawdown.

Analysis of competing companies

Company Sales Volume TEM (tempus.com)|Company Sales QGEN (Qiagen N.V.)|IONS (ionispharma.com) - Company Sales Revenue|Revenue and Sales Volume RNA (Avidity Biosciences, Inc.)|CRSP - Company Sales|WGS - Company Revenue|Company Total Revenue Ultragenyx Corp|Beam Therapeutics Inc. (BEAM) - Company Revenue|sarepta.com - Company Sales Revenue|Company Revenue Twist Bioscience, Inc.|10x Genomics Inc - Company Annual Revenue|Company Revenue Intellia (NTLA)|STOK - Company Total Revenue|Company Revenue BioLife Solutions, Inc. BLFS|Company Sales Revenue WVE|Maze Therapeutics - Revenue and Sales Volume|SION - Revenue and Sales Volume|PRME (Prime Medicine Corp) - Company Sales|TSHA: Company Total Sales|QURE (uniQure N.V.) - Revenue and Sales Volume|meiragtx.com (MGTX) - Company Gross Revenue|Company Revenue REGENXBIO (RGNX)|SLDB - Company Total Revenue|Company Revenue Ocugen Corp OCGN|PACB: Company Sales Volume|BNTC - Company Revenue|Company Sales Revenue DSGN (designtx.com)|RCKT: Revenue and Sales Volume|Company Total Sales Volume 4DMT FDMT|LXEO (Lexeo Therapeutics Inc.) - Revenue and Sales Volume|Company Total Revenue Korro Bio, Inc KRRO|Company Revenue Editas Medicine, Inc. (EDIT)|silence-therapeutics.com - Company Sales Volume|Revenue and Sales Volume PRQR (ProQR Therapeutics)|CDXS: Company Sales Volume|SGMO - Company Revenue|NAUT (Nautilus Biotechnology) - Company Sales Volume|MGX: Revenue and Sales Volume|Precision BioSciences Inc. (DTIL) - Revenue and Sales Volume|Company Revenue Generation Bio Co|BOLD: Company Sales Revenue|Revenue and Sales Volume XCUR|IMNN - Company Total Revenue|Company Revenue Phio Pharmaceuticals Corp. PHIO|MBIO (Mustang Bio Inc) - Company Annual Revenue|RNAZ - Company Revenue|BNGO: Company Revenue|APDN: Revenue and Sales Volume|BLUE - Company Gross Revenue|IPA (ImmunoPrecise Antibodies Ltd) - Revenue and Sales Volume|OMGA - Company Total Sales Volume|Revenue and Sales Volume OMIC|RGLS - Company Total Revenue|Company Revenue Syros SYRS|TBIO: Company Sales Volume|TCON: Company Sales|Company Sales Revenue UBX (unitybiotechnology.com)